Hepatitis B, Chronic Clinical Trials

11 recruiting

Hepatitis B, Chronic Trials at a Glance

12 actively recruiting trials for hepatitis b, chronic are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Shanghai, Guangzhou, and Xi'an. Lead sponsors running hepatitis b, chronic studies include Huashan Hospital, Third Affiliated Hospital, Sun Yat-Sen University, and AusperBio Therapeutics Inc..

Browse hepatitis b, chronic trials by phase

Treatments under study

About Hepatitis B, Chronic Clinical Trials

Looking for clinical trials for Hepatitis B, Chronic? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hepatitis B, Chronic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hepatitis B, Chronic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 2

Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region

Hepatitis B, Chronic
AusperBio Therapeutics Inc.84 enrolled8 locationsNCT07370207
Recruiting

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Hepatitis B, Chronic (CHB)Hepatitis BHepatitis B Virus (HBV)
First Affiliated Hospital Xi'an Jiaotong University1,500 enrolled2 locationsNCT07079150
Recruiting
Phase 2

Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]

Hepatitis B, Chronic
University Health Network, Toronto15 enrolled1 locationNCT06216470
Recruiting
Phase 4

Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients

Hepatitis B, Chronic
Third Affiliated Hospital, Sun Yat-Sen University5,000 enrolled1 locationNCT05182463
Recruiting

National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses

Hepatitis B, ChronicHepatitis D, Chronic
ANRS, Emerging Infectious Diseases800 enrolled38 locationsNCT04166266
Recruiting

Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF

Acute-On-Chronic Liver FailureHepatitis B, Chronic
Third Affiliated Hospital, Sun Yat-Sen University200 enrolled1 locationNCT04597164
Recruiting

Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion

Hepatitis B, Chronic
Huashan Hospital300 enrolled1 locationNCT06550622
Recruiting

A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B

Hepatitis B, Chronic
Tongji Hospital250 enrolled5 locationsNCT06525909
Recruiting

HBsAg Declined Patients Follow-up Study

Hepatitis BHepatitis B, Chronic
Nanfang Hospital, Southern Medical University100 enrolled1 locationNCT05977283
Recruiting

Real-world Study Optimizing Nucleotide-analogues

Hepatitis B, Chronic
Huashan Hospital20,000 enrolled44 locationsNCT05937178
Recruiting
Early Phase 1

Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B

Hepatitis B, Chronic
Anhui Medical University1,084 enrolled1 locationNCT05922306
Recruiting

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)

Carcinoma, HepatocellularNon-Alcoholic Fatty Liver DiseaseCirrhosis, Liver+2 more
Ruijin Hospital20,000 enrolled1 locationNCT05870969